Urovant Sciences Announces Progression of URO-902 Phase 2a Trial Following Positive Recommendation from the Data and Safety Monitoring Board

IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Urovant Sciences Announces Progression of URO-902 Phase 2a Trial Following Positive Recommendation from the DSMB